BTKi-Containing Triplet Active in Relapsed/Untreated Mantle Cell Lymphoma

November 23, 2020

Results from the study were published in Blood and showed that obinutuzumab plus ibrutinib and venetoclax as treatment of patients with relapsed and untreated mantle cell lymphoma achieved high response rates with favorable tolerability.

Exploring First-line Therapies in Peripheral T-Cell Lymphomas

November 23, 2020

During the Targeted Oncology Case Based Peer Perspectives event, Javier L. Munoz, MD, Hematologist/Oncologist Director, Lymphoma Program Mayo Clinic, discussed the case of 60-year-old patient with peripheral T-cell lymphoma.

Despite Advances in Precision Medicine, Disparities Persist

November 23, 2020

The goal of precision medicine is to advance medical and scientific discoveries while offering more tailored, precise, and accurate health interventions, thus maximizing health benefits for patients while reducing adverse effects and overall cost of care.

Overcoming Widespread Effects of COVID-19 Calls for Resilience, Perseverance

November 22, 2020

The economic impact of the pandemic, which is still taking shape, will likely lead to many patients being uninsured, resulting in less access to medical care and ultimately culminating in an uptick in cancer-related mortality in the years ahead.

Many Oncologists Favor Consolidation Immunotherapy Following Chemoradiation for Stage III NSCLC

November 21, 2020

During a Targeted Oncology Case Based Peer Perspectives event, John Heymach, MD, PhD, professor and Chair, David Bruton Jr Chair in Cancer Research. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, discussed the guidelines and therapeutic option for stage III non–small cell lung cancer, based on a case of a 66-year-old patient.

Incorporating Genomics into Lymphoma Classification Can Improve Care

November 21, 2020

The incorporation of genomics into the classification and treatment decision-making process for lymphomas is possible; however, many obstacles have prevented the incorporation of sequencing into standard practice, according to Sandeep Dave, MD.

Big Data–Based Tools Support Cancer Clinical Decision-Making

November 20, 2020

Clinicians are increasingly looking to big data and electronic medical records (EMR) data integration tools in support of clinical decision-making questions and processes for improved access and care for their patients with cancer.